• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

QD-7量表:用单一量表衡量不同医疗状况对特定疾病生活质量的影响。

The QDIS-7: using one scale to measure the disease-specific quality-of-life impact of different medical conditions.

作者信息

Fukuhara Shunichi, Green Joseph, Wakita Takafumi, Yamamoto Yosuke, Yamazaki Hajime, Ware John E

机构信息

Section of Clinical Epidemiology, Department of Community Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

CiRCLE and Shirakawa STAR, Fukushima Medical University, Fukushima, Japan.

出版信息

Sci Rep. 2025 Jul 1;15(1):21756. doi: 10.1038/s41598-025-05963-5.

DOI:10.1038/s41598-025-05963-5
PMID:40594348
Abstract

When measuring disease-specific quality of life (QOL), scores from different instruments can almost never be compared, so clinical and research questions involving more than one disease cannot be answered. To overcome that limitation, the Quality of Life Disease Impact Scale (QDIS-7) uses standardized content and only one metric. We tested whether QDIS-7 scores are comparable across diseases. In an online survey, 2,627 adults who had sought care for headache, low-back pain, asthma, or diabetes, responded to the QDIS-7 and to a previously-validated disease-specific QOL instrument ("legacy scale") that measured QOL in their specific disease. Using the slopes of four independent regressions of legacy-scale scores on QDIS-7 scores, we tested the hypothesis that QDIS-7 scores can be compared across those four different medical conditions. The four regression-line slopes were nearly identical: 0.12 to 0.14 legacy-scale standard deviations per 1-point difference in QDIS-7 score. Thus, each 10-point difference in QDIS-7 scores was equal to slightly more than one standard-deviation difference in legacy-scale scores, for all four groups. The equivalence of the four slopes supports the use of the QDIS-7 to compare disease-specific QOL across different medical conditions. Thus, QDIS-7 users can answer clinical and research questions that are otherwise impossible to address.

摘要

在测量特定疾病的生活质量(QOL)时,几乎无法比较不同测评工具得出的分数,因此涉及一种以上疾病的临床和研究问题无法得到解答。为克服这一局限,生活质量疾病影响量表(QDIS - 7)采用了标准化内容且仅使用一种度量标准。我们测试了QDIS - 7分数在不同疾病之间是否具有可比性。在一项在线调查中,2627名曾因头痛、腰痛、哮喘或糖尿病就医的成年人对QDIS - 7以及一种先前经验证的特定疾病生活质量测评工具(“传统量表”)做出了回应,该传统量表用于测量他们所患特定疾病的生活质量。通过对传统量表分数与QDIS - 7分数进行四项独立回归分析的斜率,我们检验了QDIS - 7分数可在这四种不同医疗状况之间进行比较的假设。四条回归线的斜率几乎相同:QDIS - 7分数每相差1分,相当于传统量表标准差相差0.12至0.14。因此,对于所有四组而言,QDIS - 7分数每相差10分,就相当于传统量表分数相差略多于一个标准差。四条斜率的等同性支持使用QDIS - 7来比较不同医疗状况下特定疾病的生活质量。因此,使用QDIS - 7的人员能够回答那些原本无法解决的临床和研究问题。

相似文献

1
The QDIS-7: using one scale to measure the disease-specific quality-of-life impact of different medical conditions.QD-7量表:用单一量表衡量不同医疗状况对特定疾病生活质量的影响。
Sci Rep. 2025 Jul 1;15(1):21756. doi: 10.1038/s41598-025-05963-5.
2
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
3
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.
4
Selective progesterone receptor modulators (SPRMs) for uterine fibroids.用于子宫肌瘤的选择性孕激素受体调节剂(SPRMs)
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD010770. doi: 10.1002/14651858.CD010770.pub2.
5
Medically assisted hydration for adults receiving palliative care.对接受姑息治疗的成年人进行医学辅助水化。
Cochrane Database Syst Rev. 2023 Dec 14;12(12):CD006273. doi: 10.1002/14651858.CD006273.pub4.
6
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Noninvasive Vagus Nerve Stimulation for Cluster Headache and Migraine: A Health Technology Assessment.用于丛集性头痛和偏头痛的非侵入性迷走神经刺激:一项卫生技术评估
Ont Health Technol Assess Ser. 2025 May 1;25(2):1-177. eCollection 2025.
9
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Validation of a new instrument for measuring disease-specific quality of life: A pilot study among patients with chronic kidney disease and hyperkalemia.一种用于测量疾病特异性生活质量的新工具的验证:一项针对慢性肾脏病和高钾血症患者的试点研究。
Ann Clin Epidemiol. 2022 Sep 29;5(1):13-19. doi: 10.37737/ace.23003. eCollection 2023.
2
The Japanese version of Problem Areas in Diabetes Scale: a clinical and research tool to assess emotional functioning among people with diabetes.糖尿病问题领域量表日文版:一种用于评估糖尿病患者情绪功能的临床及研究工具。
Diabetol Int. 2023 Sep 13;15(1):117-122. doi: 10.1007/s13340-023-00661-x. eCollection 2024 Jan.
3
Impact of treatment of hyperkalaemia on quality of life: design of a prospective observational cohort study of long-term management of hyperkalaemia in patients with chronic kidney disease or chronic heart failure in Japan.
高钾血症治疗对生活质量的影响:一项在日本对慢性肾脏病或慢性心力衰竭患者高钾血症长期管理的前瞻性观察队列研究的设计。
BMJ Open. 2023 Dec 14;13(12):e074090. doi: 10.1136/bmjopen-2023-074090.
4
Health-Related Quality of Life Scores and Values as Predictors of Mortality: A Scoping Review.健康相关生活质量评分和价值观作为死亡率预测因素的研究综述。
J Gen Intern Med. 2023 Nov;38(15):3389-3405. doi: 10.1007/s11606-023-08380-4. Epub 2023 Aug 31.
5
Development and Initial Psychometric Validation of the COVID-19 Pandemic Burden Index for Healthcare Workers.《医护人员 COVID-19 大流行负担指数的制定与初步心理测量学验证》。
J Gen Intern Med. 2023 Apr;38(5):1239-1247. doi: 10.1007/s11606-023-08028-3. Epub 2023 Jan 18.
6
The challenges inherent with anchor-based approaches to the interpretation of important change in clinical outcome assessments.基于锚定的方法在解释临床结局评估中重要变化时所固有的挑战。
Qual Life Res. 2023 May;32(5):1239-1246. doi: 10.1007/s11136-022-03297-7. Epub 2022 Nov 18.
7
The Maternal Postpartum Quality of Life Instrument (MPQOL-I): development and psychometric evaluation in an exploratory sequential mixed-method study.产妇产后生活质量量表(MPQOL-I):在探索性序贯混合方法研究中的开发和心理测量评估。
BMC Pregnancy Childbirth. 2022 Jul 19;22(1):576. doi: 10.1186/s12884-022-04900-y.
8
Improving multimorbidity measurement using individualized disease-specific quality of life impact assessments: predictive validity of a new comorbidity index.利用个体化疾病特异性生活质量影响评估改善多病共存测量:新合并症指数的预测效度。
Health Qual Life Outcomes. 2022 Jul 12;20(1):108. doi: 10.1186/s12955-022-02016-7.
9
Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure.2019冠状病毒病患者的健康相关生活质量;患者报告结局指标的国际开发
J Patient Rep Outcomes. 2022 Mar 26;6(1):26. doi: 10.1186/s41687-022-00434-1.
10
Minimal important changes in standard deviation units are highly variable and no universally applicable value can be determined.标准差单位的最小有意义变化具有高度可变性,无法确定普遍适用的值。
J Clin Epidemiol. 2022 May;145:92-100. doi: 10.1016/j.jclinepi.2022.01.017. Epub 2022 Jan 25.